Efficacy of the salmeterol/fluticasone propionate dry powder combination product in the Diskus®:: A stratified study in patients on salmeterol alone or inhaled corticosteroids.

被引：0
|
作者：
Wolfe, J
Bell, T
Raphael, G
Weinstein, S
Baitinger, L
Woodring, A
Prillaman, B
House, K
Shah, T
机构：
[1] Allergy & Asthma Assoc Santa Clara Valley, San Jose, CA USA
[2] Ctr Asthma & Allergy, Missoula, MT USA
[3] Allergy & Asthma Specialists Med Grp, Huntington Beach, CA USA
[4] Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA
[5] Adult & Pediat Allergy & Immunol, Bethesda, MD USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1999年 / 103卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
879
引用
收藏
页码：S228 / S228
页数：1
相关论文
共 50 条
  • [1] The salmeterol/fluticasone propionate combination (50/100mcg) via diskus® has a rapid onset of effect in asthma patients on salmeterol or inhaled corticosteroids
    Nathan, R
    LaForce, C
    Mitchell, D
    Pearlman, D
    Baitinger, L
    Woodring, A
    House, K
    Prillaman, B
    Shah, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A637 - A637
  • [2] The salmeterol/fluticasone propionate (50/250mcg) dry powder combination Diskus® has a faster onset of effect compared with salmeterol or fluticasone propionate in patients with asthma.
    Lumry, W
    Windom, H
    Mendelson, L
    Pedinoff, A
    Prillaman, B
    Baitinger, L
    Woodring, A
    House, K
    Shah, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S132 - S132
  • [3] The effect of inhaled salmeterol, alone and in combination with fluticasone propionate, on management of COPD patients
    Mansori, Fariba
    Khorasani, Anaiatolah Nemat
    Boskabady, Mohammad Hossein
    Boskabady, Morteza
    CLINICAL RESPIRATORY JOURNAL, 2010, 4 (04): : 241 - 247
  • [4] THE EFFECT OF INHALED SALMETEROL ALONE AND IN COMBINATION WITH FLUTICASONE PROPIONATE ON THE MANAGEMENT OF COPD PATIENTS
    Mansouri, F.
    Khorasani, E.
    RESPIRATORY MEDICINE, 2017, 132 : 273 - 273
  • [5] The salmeterol xinafoate/fluticasone propsonate dry powder combination product via diskus. inhaler improves asthma control compared to tee individual products in patients previously treated with inhaled corticosteroids.
    White, M
    Shapiro, G
    Taylor, J
    Dunn, K
    Woodring, A
    Baitinger, L
    Prillaman, B
    House, K
    Shah, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A635 - A635
  • [6] The comparative study of the efficacy of fluticasone propionate/salmeterol combination versus fluticasone propionate alone in moderate asthma
    Breskovska, G.
    Kaeva, B.
    Stojkovoc, J.
    Stevcevska, G.
    Gligorovski, L.
    Gerovski, B.
    ALLERGY, 2008, 63 : 606 - 607
  • [7] Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects
    Kirjavainen, Merja
    Mattila, Leena
    Vahteristo, Mikko
    Korhonen, Jani
    Lahelma, Satu
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2018, 31 (05) : 290 - 297
  • [8] Fluticasone propionate/salmeterol Diskus® combination product provides superior asthma control compared with fluticasone propionate and salmeterol alone in patients previously receiving PRN short-acting beta2-agonists alone
    Rosenthal, RR
    Blake, K
    Strek, M
    Lange, M
    House, KW
    Vandermeer, AK
    Shah, TP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S245 - S245
  • [9] Efficacy Of Fluticasone And Salmeterol In A Novel Inhaled Dry Powder Delivery Platform
    Arold, S.
    Manzanedo, D.
    Kong, S.
    Saia, F.
    Sung, J.
    Lipp, M.
    Clarke, R. W.
    Hava, D. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [10] Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting β2-agonists
    Murray, J
    Rosenthal, R
    Somerville, L
    Blake, K
    House, K
    Baitinger, L
    VanderMeer, A
    Dorinsky, P
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 93 (04) : 351 - 359
12345